ClonoSEQ Reference Testing Service
ID: PANHCA24P0000007774Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/b80bad36f9e04a5eb89282f9b78052de/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is seeking qualified contractors to provide ClonoSEQ Reference Testing Services for the Brooke Army Medical Center (BAMC) located in Fort Cavazos, Texas. The contractor will be responsible for delivering FDA-cleared in vitro diagnostic testing services, specifically the ClonoSEQ® assay, which is crucial for detecting measurable residual disease in patients with certain hematologic malignancies. This procurement is vital for monitoring cancer treatment and ensuring timely processing and reporting of test results, with a contract duration starting from April 1, 2025, to March 31, 2026, and options to extend through March 31, 2029. Interested parties must submit their capability statements by February 7, 2025, and should contact Colleen Rye or Salameya Paulouskaya for further information.

    Point(s) of Contact
    Colleen Rye
    colleen.m.rye.civ@health.mil
    Salameya Paulouskaya
    (210) 539-8656
    (210) 221-3446
    salameya.paulouskaya2.civ@health.mil
    Files
    Title
    Posted
    Souces Sought ClonoSEQ.pdf
    The Brooke Army Medical Center (BAMC) is issuing a Sources Sought Notice to procure FDA-cleared in vitro diagnostic (IVD) testing services, specifically for the ClonoSEQ® assay from Adaptive Biotechnologies Corporation. This assay detects measurable residual disease in patients with certain hematologic malignancies. The notice serves as a market research tool to identify businesses with the capability to deliver these specialized testing services, encouraging participation from all interested parties, particularly small businesses across various designations. Interested respondents are asked to provide detailed capability statements outlining their organizational capacities and relevant experience. The government emphasizes that this notice does not constitute a request for proposals or obligate them to award a contract. Interested organizations must also provide information about their size classification under the NAICS code 621511 for Medical Laboratories. Responses are required by 07 February 2025, and businesses must register in the System for Award Management (SAM) to be eligible for future solicitations. This initiative illustrates the government's approach to identifying potential vendors capable of meeting specific healthcare service needs while fostering small business participation.
    SOW.pdf
    The Statement of Work (SOW) outlines the provision of Clinical Reference Testing Services by Adaptive Biotechnologies Corporation (ClonoSEQ®) for the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. This contract entails non-personnel services, where the contractor is responsible for all necessary resources for comprehensive ClonoSEQ testing, including the provision and transport of specimens. Key requirements involve timely processing and reporting of test results, specifically for measurable residual disease in patients with certain hematological cancers. A systematic approach to specimen handling, processing, and result reporting is mandated, with results to be transmitted securely to BAMC's Hematology/Oncology Clinic. The contract has a base year from April 1, 2025, to March 31, 2026, with four option years extending until March 31, 2029. Invoicing must follow specific guidelines, including submission through WAWF and clear labeling of final invoices. This document serves to ensure compliance and facilitate the execution of essential laboratory testing services, pivotal for cancer treatment monitoring at BAMC.
    Lifecycle
    Title
    Type
    ClonoSEQ Reference Testing Service
    Currently viewing
    Sources Sought
    Similar Opportunities
    Sources Sought Notice - Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to include reagents, molecular PCR instrument/equipment, consumables, maintenance support and instrument warranties at BAMC.
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources for a Cost-Per-Test (CPT) Agreement or Reagent Rental Agreement to support molecular genetic and infectious disease testing at the Brooke Army Medical Center (BAMC) in Fort Cavazos, Texas. The procurement includes the provision of molecular PCR instruments, reagents, consumables, maintenance support, and instrument warranties, with a base performance period from October 1, 2025, to September 30, 2030. This initiative is critical for enhancing the laboratory's capabilities in conducting various genetic tests, including those for Celiac Disease, Alzheimer’s Disease, and a comprehensive Dermatomycosis Panel, which are essential for informed health assessments and treatment decisions. Interested parties are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil, by the specified deadlines, as this notice is solely for information and planning purposes and does not constitute a solicitation.
    Sources Sought Notice for Chemiluminescent immunoassay (CLIA) kits compatible with the government’s current CLIA instrumentation for the Brooke Army Medical Center (BAMC).
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources to provide Chemiluminescent immunoassay (CLIA) kits compatible with the existing CLIA instrumentation at the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement aims to secure FDA-approved assay kits that meet specific testing requirements, including rapid turnaround times and comprehensive training for laboratory staff. This initiative is crucial for maintaining efficient laboratory services and public health monitoring, as it supports a range of immunological tests essential for patient care. Interested vendors are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil by the specified deadline, with a base performance period anticipated from October 1, 2025, to September 30, 2030.
    Q301--VISN22 REFERENCE LAB TESTING SERVICES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide Reference Lab Testing Services under the solicitation number 36C26225Q0310 for various facilities within the Veterans Integrated Service Network 22 (VISN 22), which includes locations in California, New Mexico, Arizona, and associated outpatient clinics. The objective is to establish a single Indefinite Delivery/Indefinite Quantity (IDIQ) contract that encompasses specimen processing, testing with defined turnaround times, secure courier transportation, and compliance with cybersecurity and HIPAA protocols. This initiative is crucial for ensuring timely and efficient laboratory services for veterans' healthcare, with a contract budget ranging from $1,000 to $50 million, and implementation expected within 120 days of award. Interested parties must submit their capability statements by February 4, 2025, and can contact Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov for further information.
    Q301--FY25 4/1/2025-3/31/2030 Jonathan M. Wainwright Memorial VA Medical Center New Reference Lab Five Year Contract
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking contractors to provide reference laboratory testing services for the Jonathan M. Wainwright Memorial VA Medical Center, with a contract period from April 1, 2025, to March 31, 2030. The procurement includes a base year and four optional one-year periods, aimed at fulfilling the requirements outlined in the Statement of Work (SOW) attached to the Sources Sought Notice. This contract is critical for ensuring the availability of medical laboratory testing services, which are essential for the healthcare needs of veterans. Interested contractors must submit their responses by January 28, 2024, including relevant documentation and assurances of compliance with regulatory standards, to Hector Gonzalez at hector.gonzalez1@va.gov.
    Microbial Testing Supplies - Bridge Contract
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Hematology CPRR - Keesler AFB, MS
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for a hematology system to be delivered to the Keesler Medical Center at Keesler Air Force Base in Mississippi. The procurement requires one hematology system that includes two functioning analyzers, a slide maker stainer, and a digital cell morphology system equipped with advanced software for red blood cell morphology. This system is crucial for enhancing patient care and operational capabilities within military healthcare, as it will facilitate the processing of 31,000 complete blood counts over a five-year period. Interested vendors must ensure that their equipment is FDA-approved, meets specific technical specifications, and complies with cybersecurity standards as outlined in the Medical Device and Equipment Risk Assessment. The deadline for proposals has been extended to January 24, 2025, with the period of performance beginning on April 1, 2025. For further inquiries, interested parties can contact Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil.
    Service Contract for the Applied Biosystems Quantstudio FLEX 6 and 7 Real-Time PCR Instruments
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army Corps of Engineers, is seeking a contractor to provide comprehensive service and maintenance for the Applied Biosystems Quantstudio FLEX 6 and 7 Real-Time PCR instruments. The contract requires unlimited on-site service and repair, one preventive maintenance visit annually, and high-priority remote support, all to be performed by certified technicians to ensure the instruments remain operational for critical research activities. These instruments play a vital role in monitoring environmental stressors, significantly contributing to research in toxicology and environmental management. Interested contractors should contact Amanda Andrews at amanda.andrews@usace.army.mil or 601-634-5249 for further details, with the solicitation document available for review under Contract Number W912HZ25Q0011.
    Blood Coagulation Analyzer and Reagents
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking qualified contractors to provide a Blood Coagulation Analyzer and associated reagents for the Womack Army Medical Center at Fort Liberty, North Carolina. The procurement aims to acquire hemostasis automation systems, which include comprehensive services such as personnel, equipment, installation, training, and ongoing maintenance, ensuring compliance with health regulations and integration with the military hospital's information system. This initiative is critical for maintaining high-quality healthcare services within military medical facilities, emphasizing rapid turnaround times for critical tests and adherence to safety and quality standards. Interested parties must submit their capabilities statements by 2 PM EST on January 31, 2025, to the designated contacts, Victoria Manigault and Michael J. McCollum, via email.
    Quarterly Mobile Mammogram Services
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking contractors to provide quarterly Mobile Mammogram Services at the Weed Army Community Hospital in Fort Irwin, California. The contractor will be responsible for deploying a fully equipped 3D high-definition mobile mammography unit to conduct on-site screenings for up to 36 participants each quarter, ensuring compliance with safety and quality standards while delivering test results to patients within 24 hours. This service is crucial for enhancing healthcare accessibility for military personnel and their families, adhering to regulatory requirements and maintaining high-quality patient care. Interested bidders should contact Kevin Vijayan at kevin.vijayan.civ@health.mil or 210-538-4861, with proposals due by January 16, 2025, at 10 AM CST.
    Blood Chemistry Analyzers - JBSA Lackland, TX
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking to lease two Blood Chemistry Analyzers for the Wilford Hall Medical Center and Blood Donor Center at Joint Base San Antonio-Lackland, Texas. The procurement aims to support the medical processing of approximately 30,000 Basic Military Trainees and the collection of 10,000 blood units, necessitating analyzers that comply with specific testing protocols and operational requirements. This initiative underscores the importance of maintaining high standards in military medical services by ensuring the availability of essential medical equipment and support. Interested vendors must submit questions by January 16, 2025, and the lease period is set from April 4, 2025, to April 3, 2026; for further inquiries, contact Kimberly A. Woods at kimberly.a.woods4.civ@health.mil or Johanna House at johanna.m.house.civ@health.mil.